Search

Search Constraints

You searched for: Author/Creator Kitade, Mitsuteru

Search Results

1. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein. (10th October 2018)

2. Blocking development of liver fibrosis augments hepatic progenitor cell‐derived liver regeneration in a mouse chronic liver injury model. Issue 9 (29th May 2019)

3. Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase‐4 inhibitor on hepatic fibrosis. Issue 10 (15th July 2019)

4. Combined treatment with dipeptidyl peptidase‐4 inhibitor (sitagliptin) and angiotensin‐II type 1 receptor blocker (losartan) suppresses progression in a non‐diabetic rat model of steatohepatitis. Issue 12 (13th February 2017)

5. Dual blockade of angiotensin‐II and aldosterone suppresses the progression of a non‐diabetic rat model of steatohepatitis. Issue 7 (20th November 2012)

6. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis. Issue 9 (19th September 2017)

7. Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis. Issue 7 (10th June 2020)

8. Identification of clinical risk factors for histological progression of primary biliary cholangitis. Issue 9 (14th June 2019)

9. Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis. Issue 3 (21st July 2016)

10. Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis. Issue 3 (20th July 2017)